SCHEMBL197122

SCHEMBL197122

CN(C)[C@@H](CS)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL197121 1.00
SCHEMBL8721546 1.00
Hydrochloric Acid SCHEMBL9807458 0.97 PTGS1 (0.39)
Hydrochloric Acid SCHEMBL8945311 0.97 PTGS1 (0.39)
Hydrochloric Acid SCHEMBL9807456 0.97 PTGS1 (0.39)
Hydrochloric Acid SCHEMBL8945317 0.97 PTGS1 (0.39)
Carbamic Acid SCHEMBL30002433 0.93 PTGS1 (0.41)
SCHEMBL9298599 0.82
SCHEMBL8345827 0.82
SCHEMBL4263223 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 478 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120118311-A Continuous method for preparing TMQ polymer, product and application 上海华谊新材料有限公司 2025-06-10 CN claimed
US-20230331767-A1 TARGETED STEROID COMPOUNDS PURDUE RESEARCH FOUNDATION 2023-10-19 US claimed
EP-4087580-A1 TARGETED STEROID COMPOUNDS Purdue Research Foundation (US) 2022-11-16 EP claimed
CN-115003308-A Targeted steroid compounds 普渡研究基金会 2022-09-02 CN claimed
US-20160244484-A1 ANTI-INFLAMMATORY TRIPEPTIDES DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2016-08-25 US claimed
EP-3049428-A1 ANTI-INFLAMMATORY TRIPEPTIDES Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) 2016-08-03 EP claimed
WO-2015040235-A1 ANTI-INFLAMMATORY TRIPEPTIDES DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-03-26 WO claimed
EP-0948258-A4 BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS YISSUM RES DEV CO (IL) 2004-12-01 EP claimed
EP-0948258-A1 BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1999-10-13 EP claimed
WO-1998029375-A1 BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1998-07-09 WO claimed
EP-3381434-B1 DENTAL PRIMER AND KIT FOR DENTAL PROSTHESIS ADHESION G C DENTAL IND CORP (JP) 2026-04-29 EP disclosed
EP-4688001-A1 AN INJECTABLE DELIVERY SYSTEM FOR LONG-ACTING ADMINISTRATION OF DRUGS Queen's University of Belfast (GB) 2026-02-11 EP disclosed
US-12497476-B2 Antibacterial polymer particles, composition, and article GC CORPORATION (JP) 2025-12-16 US disclosed
WO-2025215218-A1 PEPTIDES AND PEPTIDOMIMETICS TO DESTABILIZE THE SYNAPTIC COMPLEX OF A RECOMBINASE Technische Universität Dresden, Körperschaft des öffentlichen Rechts (DE) 2025-10-16 WO disclosed
US-20250222117-A1 COMPOUND COMPRISING RALTITREXED OR 5-MTHF LINKED TO A THERAPEUTIC AGENT, COMPOSITION, AND METHOD OF USE PURDUE RESEARCH FOUNDATION 2025-07-10 US disclosed
EP-0341915-A2 Anti-aggregatory peptides SMITHKLINE BEECHAM CORPORATION (US) 1989-11-15 EP disclosed
EP-0226591-A1 ANTI-TUMOR COMPOSITIONS CONTAINING THE REACTION PRODUCT OF A CYTOTOXIC ALDEHYDE WITH PENICILLAMINE AND THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS. RUBIN DAVID 1987-07-01 EP disclosed
EP-0226591-A4 ANTI-TUMOR COMPOSITIONS CONTAINING THE REACTION PRODUCT OF A CYTOTOXIC ALDEHYDE WITH PENICILLAMINE AND THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS. RUBIN DAVID 1987-06-01 EP disclosed
WO-1986003677-A1 ANTI-TUMOR COMPOSITIONS CONTAINING THE REACTION PRODUCT OF A CYTOTOXIC ALDEHYDE WITH PENICILLAMINE AND METHOD OF USE THEREOF RUBIN DAVID 1986-07-03 WO disclosed
US-4344956-A Oxotetrahydrothiophenes ERCOLI NICOLO 1982-08-17 US disclosed